GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Petros Pharmaceuticals
Petros Pharmaceuticals specializes in men's health products. Its stock price reflects its competition for market share and the commercial success of its products. Its price is volatile and depends on sales news and marketing efforts.
Share prices of companies in the market segment - Pharma other
Petros Pharmaceuticals is a pharmaceutical company focused on men's health, specifically erectile dysfunction medications. We've classified it in the "Other Pharma" category. The chart below shows how investors value companies operating in niche segments.
Broad Market Index - GURU.Markets
Petros Pharmaceuticals is a pharmaceutical company focused on men's health, specifically erectile dysfunction medications. We've classified it in the "Other Pharma" category. The chart below shows how investors value companies operating in niche segments.
Change in the price of a company, segment, and market as a whole per day
PTPI - Daily change in the company's share price Petros Pharmaceuticals
The daily price change of Petros Pharmaceuticals, Inc. reflects volatility in the pharmaceutical sector. The indicator demonstrates sensitivity to sales of its men's health products, serving as an indicator of commercial success.
Daily change in the price of a set of shares in a market segment - Pharma other
Petros Pharmaceuticals specializes in men's health products. This pharmaceutical segment has its own unique dynamics and competitive landscape. The chart below shows the volatility in this niche, allowing you to compare PTPI stock performance with other market players.
Daily change in the price of a broad market stock, index - GURU.Markets
Petros Pharmaceuticals is a pharmaceutical company focused on men's health. Its shares are highly volatile and depend on the results of clinical trials and the commercial success of its drugs. These scientifically based movements are part of the complex picture of the overall stock market.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Petros Pharmaceuticals
Petros Pharmaceuticals' year-over-year performance tells the story of its performance in the men's health market. Its market cap change over the past 12 months reflects its success in selling its erectile dysfunction drug, Stendra®. Its valuation is a bet on its ability to successfully compete with more established brands like Viagra and Cialis.
Annual dynamics of market capitalization of the market segment - Pharma other
Petros, a commercial pharmaceutical company, specializes in men's health. The chart shows how its niche strategy, sales success of its key drug, and the competitive environment influence its performance in the pharmaceutical sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Petros Pharmaceuticals, which operates in the men's health market, demonstrates its competitive edge in the over-the-counter (OTC) segment with its performance. Its performance against the market is a test of the strength of its brands and the effectiveness of its marketing in winning consumer attention.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Petros Pharmaceuticals
Petros is a pharmaceutical company focused on men's health. Its monthly performance is driven by sales of its medications. Quarterly revenue reports and its efforts to expand access to its products are key.
Monthly dynamics of market capitalization of the market segment - Pharma other
Petros Pharmaceuticals focuses on men's health, offering medications for erectile dysfunction and other conditions. The chart below shows the overall trend in the pharmaceutical sector, reflecting the demand for medications that improve quality of life.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Shares of pharmaceutical companies operating in the men's health sector can move independently of the market. The chart below shows general trends. Is Petros Pharmaceuticals following the sales growth of its niche products?
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Petros Pharmaceuticals
Petros, a pharmaceutical company specializing in men's health, shares reflect demand in this area on a weekly basis. Their stock price responds to sales of their medications and the company's ability to bring new products to market to address men's health concerns.
Weekly dynamics of market capitalization of the market segment - Pharma other
Petros Pharmaceuticals focuses on men's health, offering medications for erectile dysfunction. This chart compares its weekly performance with the pharmaceutical sector and helps us understand how its niche specialization and marketing efforts enable it to compete in this market.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Petros Pharmaceuticals is a pharmaceutical company. Its success depends on the commercialization of its products. This chart will help you understand: do Petros shares live their own lives, reacting to sales volumes and news, or are their trends driven by the overall dynamics of the pharmaceutical sector and the market?
Market capitalization of the company, segment and market as a whole
PTPI - Market capitalization of the company Petros Pharmaceuticals
The Petros Pharma market capitalization chart tells the story of a company focused on men's health. Its dynamics reflect its strategy of selling medications, including those for erectile dysfunction, through online channels. Its trajectory reflects the market's assessment of its ability to compete in this niche and expand its product portfolio.
PTPI - Share of the company's market capitalization Petros Pharmaceuticals within the market segment - Pharma other
Petros Pharmaceuticals specializes in men's health. The company's share of the overall pharmaceutical market capitalization is small, indicating its narrow focus. The chart below illustrates how the market evaluates the commercial potential of its products and its ability to compete in its niche.
Market capitalization of the market segment - Pharma other
Petros Pharmaceuticals is a company focused on men's health, specifically erectile dysfunction treatment. The chart below shows the overall market capitalization of this sector. Its dynamics reflect the continued demand for medications in this area, where Petros is trying to find its niche.
Market capitalization of all companies included in a broad market index - GURU.Markets
Petros Pharmaceuticals specializes in men's health. The market capitalization of such companies reflects the demand for solutions to problems that aren't always discussed publicly. Their performance on the overall chart is an indicator of how medicine and pharmaceuticals are responding to the specific needs of different population groups.
Book value capitalization of the company, segment and market as a whole
PTPI - Book value capitalization of the company Petros Pharmaceuticals
Petros Pharmaceuticals' balance sheet represents its capital, which supports the sale of over-the-counter erectile dysfunction medications. The book value reflects the real, commercial basis of this business, which is focused on men's health. How has this niche pharmaceutical asset changed? The chart below shows its dynamics.
PTPI - Share of the company's book capitalization Petros Pharmaceuticals within the market segment - Pharma other
Petros Pharmaceuticals specializes in men's health and utilizes manufacturing and warehouse facilities for the production and distribution of its products. The chart shows the share of these tangible assets, reflecting the physical foundation of its business.
Market segment balance sheet capitalization - Pharma other
Petros, a pharmaceutical company, has a relatively lightweight model. It focuses on drug commercialization, often outsourcing manufacturing. The BCap_Seg chart for the biotech sector serves as a backdrop, showing varying levels of capital intensity.
Book value of all companies included in the broad market index - GURU.Markets
Petros Pharma's assets are not its factories, but a portfolio of brands and commercial infrastructure for selling men's health medications, primarily for the treatment of erectile dysfunction. Its balance sheet reflects its intangible and commercial assets. The chart illustrates the scale of this niche pharmaceutical player.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Petros Pharmaceuticals
Petros Pharmaceuticals focuses on men's health. Its balance sheet consists of pharmaceutical rights. Its market capitalization reflects the market's valuation of its product portfolio and its ability to successfully commercialize it. The chart shows how investors assess its position in this specific pharmaceutical niche.
Market to book capitalization ratio in a market segment - Pharma other
Petros Pharmaceuticals specializes in men's health products. Its market valuation on the chart reflects its share of this competitive market, its brands, and its strategy to expand its product line to meet patient needs.
Market to book capitalization ratio for the market as a whole
Petros Pharmaceuticals specializes in men's health products. The company's market valuation reflects the market potential of its products, not the value of its physical assets. This chart helps understand the premium investors are willing to pay for niche pharmaceutical companies compared to the market as a whole.
Debts of the company, segment and market as a whole
PTPI - Company debts Petros Pharmaceuticals
Petros Pharmaceuticals, a company specializing in men's health, uses capital to market its products and conduct research. This chart shows how the company finances its brand building and promotion efforts in a competitive market where consumer recognition and trust are key.
Market segment debts - Pharma other
Petros Pharmaceuticals specializes in men's health, specifically erectile dysfunction treatment. This chart illustrates how a small pharmaceutical company manages its finances to market its products and conduct research in a competitive and niche pharmaceutical market.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Petros Pharmaceuticals
Petros Pharmaceuticals focuses on men's health products. This chart shows how the company uses debt to market its products and conduct further research. It helps investors assess its financial strategy and sustainability in the competitive pharmaceutical market.
Market segment debt to market segment book capitalization - Pharma other
Petros Pharmaceuticals specializes in men's health, offering medications for erectile dysfunction. It's a competitive market with well-known brands. The chart shows the overall debt burden in the pharmaceutical industry, which helps assess how Petros finances its marketing and attempts to carve out its niche.
Debt to book value of all companies in the market
Petros Pharmaceuticals specializes in men's health, commercializing medications that require investment in marketing and distribution. This chart, showing the overall market debt burden, helps understand how the company manages its debt during the sales growth phase and balances promotional expenses with the pursuit of profitability.
P/E of the company, segment and market as a whole
P/E - Petros Pharmaceuticals
Petros Pharmaceuticals specializes in men's health products, particularly erectile dysfunction treatments. This chart shows how the market perceives its focus in this market. The dynamics reflect competition from established brands and generics, as well as the company's efforts to promote its products.
P/E of the market segment - Pharma other
Men's health, where Petros Pharmaceuticals markets its products, is a large market. This chart shows the average valuation for pharmaceutical companies. It helps understand how investors view Petros, its strategy for selling over-the-counter erectile dysfunction medications, and its ability to compete in this market.
P/E of the market as a whole
Petros Pharmaceuticals is a pharmaceutical company specializing in men's health. Its valuation depends on the commercial success of its products. General market sentiment, reflected in this chart, has little impact on its business, which is determined by the specifics of its niche market and competition.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Petros Pharmaceuticals
This chart for Petros Pharmaceuticals, a company focused on men's health, shows market expectations for future sales of its products. It reflects analysts' forecasts for growth in demand for erectile dysfunction medications and the company's ability to compete in this market.
%20P%2FE%20Petros%20Pharmaceuticals&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Petros-Pharmaceuticals&v=1772632281143 "Chart of the company's future (projected) P/E Petros Pharmaceuticals")
Future (projected) P/E of the market segment - Pharma other
Petros Pharmaceuticals focuses on men's health, specifically the treatment of erectile dysfunction. The company markets STENDRA and aims to make it available over-the-counter. The chart shows forecasts for the pharmaceutical industry. This helps assess how the market views Petros's strategy to make STENDRA available over-the-counter and its competition with established brands.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Pharma-other&v=1772632281144 "Future (projected) P/E graph of the market segment - Pharma other")
Future (projected) P/E of the market as a whole
Petros Pharmaceuticals, Inc. specializes in men's health products. The company operates in a market where branding and direct-to-consumer marketing are important. This graph of overall consumer sentiment shows how much men are willing to spend on health and lifestyle products, which impacts Petros' sales.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772632281145 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Petros Pharmaceuticals
Petros Pharmaceuticals focuses on men's health, offering medications for erectile dysfunction. The company's profits depend on sales of its products in a competitive market. This chart shows how the company is trying to find its niche and compete with established brands in the men's health field.
Profit of companies in the market segment - Pharma other
Petros Pharmaceuticals is focusing on men's health, commercializing Stendra for erectile dysfunction. This graph, which shows profitability in the pharmaceutical sector, demonstrates the vast and competitive nature of the lifestyle drug market. Their goal is to successfully compete with established brands by offering patients and doctors an effective and safe alternative.
Overall market profit
Petros Pharmaceuticals focuses on men's health, offering medications for erectile dysfunction. Demand for these products depends on demographic trends and awareness of the problem. This market is less sensitive to the economic cycles shown in the graph, as it is part of the larger and more stable healthcare sector.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Petros Pharmaceuticals
Petros Pharmaceuticals focuses on men's health, commercializing erectile dysfunction medications, including over-the-counter options. This chart shows analysts' assessments of sales growth in this competitive market and the success of its strategy to expand product availability.
%20profit%20of%20the%20company%20Petros%20Pharmaceuticals&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Petros-Pharmaceuticals&v=1772632281151 "Graph of future (projected) profit of the company Petros Pharmaceuticals")
Future (predicted) profit of companies in the market segment - Pharma other
Petros Pharmaceuticals focuses on men's health, commercializing medications for erectile dysfunction and other conditions. The company aims to make its products available over-the-counter. Growth depends on the success of this strategy. This chart for the pharmaceutical sector shows the general expectations for companies operating in the large consumer health market.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Pharma-other&v=1772632281152 "Graph of future (predicted) profits of companies in a market segment - Pharma other")
Future (predicted) profit of the market as a whole
Petros Pharmaceuticals specializes in men's health. Demand for its products depends on demographic trends and medical needs. The overall economic situation, reflected in this forecast, influences patients' ability to pay and their willingness to spend money on medications that improve quality of life.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772632281164 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Petros Pharmaceuticals
Petros Pharmaceuticals is a pharmaceutical company specializing in men's health. The chart shows how investors value the revenue from its commercial products. It reflects its ability to successfully sell drugs in a competitive market and the potential for portfolio expansion through new developments or acquisitions.
P/S market segment - Pharma other
Petros Pharmaceuticals focuses on men's health, offering medications for erectile dysfunction and other conditions. The company's revenue depends on sales of these products in a competitive market. This chart, which reflects the average valuation in the pharmaceutical industry, helps investors understand how the market views Petros' portfolio and marketing strategy.
P/S of the market as a whole
Petros Pharmaceuticals is a pharmaceutical company specializing in men's health, specifically erectile dysfunction treatment. This chart, showing the average market revenue estimate, helps understand how investors value the company, which operates in a niche with well-known brands but also faces strong competition from generics.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Petros Pharmaceuticals
Petros Pharmaceuticals is a pharmaceutical company focused on men's health, specifically the treatment of erectile dysfunction. The company strives to expand access to treatment, including through over-the-counter channels. This chart shows how investors view future sales and the success of its mass-market strategy.
%20P%2FS%20Petros%20Pharmaceuticals&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Petros-Pharmaceuticals&v=1772632281169 "The graph of the company's future (projected) P/S Petros Pharmaceuticals")
Future (projected) P/S of the market segment - Pharma other
Petros Pharmaceuticals, Inc. specializes in men's health, commercializing drugs to treat conditions such as erectile dysfunction. The company strives to expand access to its products. This chart shows the average estimated future sales in the pharmaceutical sector. It helps understand how the market values Petros's niche but important specialization.
%20P%2FS%20market%20segment%20graph%20-%20Pharma%20other&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Pharma-other&v=1772632281176 "Future (projected) P/S market segment graph - Pharma other")
Future (projected) P/S of the market as a whole
Petros Pharmaceuticals focuses on the development and commercialization of men's health products, primarily for the treatment of erectile dysfunction. This chart shows investor revenue growth expectations. The company operates in a large and established consumer market, striving to offer patients more convenient and affordable solutions.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772632281191 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Petros Pharmaceuticals
This chart shows the revenue of Petros Pharmaceuticals, a company specializing in men's health. Revenue is generated from sales of medications for erectile dysfunction and other conditions. The dynamics in this chart reflect the demand for its products and its competitive position in the men's health market.
Sales of companies in the market segment - Pharma other
Petros Pharmaceuticals focuses on the development and commercialization of men's health products, particularly for the treatment of erectile dysfunction. This chart reflects the dynamics of the relevant pharmaceutical market. The company strives to offer innovative and more affordable solutions, competing with established players in a large market and influencing its structure.
Overall market sales
Petros Pharmaceuticals specializes in men's health products. Demand for its products depends on consumer awareness and physician prescriptions. This total revenue chart reflects consumer spending on health and lifestyle products, which are not always covered by insurance and are income-dependent.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Petros Pharmaceuticals
Petros Pharmaceuticals focuses on the commercialization of men's health products. The company's future revenue depends on sales volumes of its products in a competitive market. This chart reflects analyst expectations for demand for erectile dysfunction medications.
%20sales%20of%20the%20company%20Petros%20Pharmaceuticals&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Petros-Pharmaceuticals&v=1772632281217 "Schedule of future (projected) sales of the company Petros Pharmaceuticals")
Future (projected) sales of companies in the market segment - Pharma other
Petros Pharmaceuticals is a pharmaceutical company focused on men's health, specifically the treatment of erectile dysfunction. The company markets and develops medications, striving to offer patients convenient and effective solutions. This chart shows the forecast for the entire pharmaceutical market, where men's health medications are a significant segment.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Pharma-other&v=1772632281220 "Schedule of future (projected) sales of companies in the market segment - Pharma other")
Future (projected) sales of the market as a whole
Petros Pharmaceuticals specializes in men's health, commercializing medications for erectile dysfunction. Demand for their products falls under the lifestyle category and is driven by discretionary spending. This chart, reflecting consumer confidence, helps assess men's willingness to spend their own money to improve their quality of life.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772632281236 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Petros Pharmaceuticals
Petros Pharmaceuticals focuses on men's health, offering medications for erectile dysfunction and other conditions. The company's profitability depends on successful sales of its products in a competitive market. This chart shows how the company strives to carve out a niche by offering patients affordable and effective solutions in men's health.
Market segment marginality - Pharma other
Petros Pharmaceuticals specializes in the commercialization of men's health medications, particularly those for erectile dysfunction. Profitability depends on successful sales of its flagship product, Stendra, and the effectiveness of its marketing efforts. This chart shows the company's operating results in the competitive men's health medication market.
Market marginality as a whole
Petros Pharmaceuticals specializes in men's health, specifically erectile dysfunction treatment. They sell their drug Stendra through online platforms. This overall profitability curve is important to them, as demand for quality-of-life medications depends on discretionary income and consumer confidence.
Employees in the company, segment and market as a whole
Number of employees in the company Petros Pharmaceuticals
Petros Pharmaceuticals specializes in men's health. The company operates with a small sales team focused on marketing its products. This chart demonstrates the compact and flexible model typical of a small pharmaceutical company with a niche portfolio.
Share of the company's employees Petros Pharmaceuticals within the market segment - Pharma other
Petros Pharmaceuticals specializes in men's health products. This chart reflects its focused commercial model. It shows the size of the small but dedicated team responsible for marketing and sales of prescription and over-the-counter products, striving to become a leader in their niche.
Number of employees in the market segment - Pharma other
Petros Pharmaceuticals, Inc. is a pharmaceutical company specializing in men's health, specifically erectile dysfunction treatment. This chart shows employment trends in the pharmaceutical sector. The growth in marketing and sales professionals reflects the company's efforts to promote its products in the highly competitive lifestyle market.
Number of employees in the market as a whole
Petros Pharmaceuticals specializes in men's health products. Demand for its products depends on patient awareness and their willingness to consult a doctor. Overall economic stability, as shown in this graph, impacts healthcare spending. People with a stable income and insurance are more likely to take care of their health.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Petros Pharmaceuticals (PTPI)
Petros Pharmaceuticals specializes in men's health, specifically selling erectile dysfunction medications (Stendra). It is a commercial pharmaceutical company. The chart shows how the market values their product and sales team. The cost per employee reflects how effectively their commercial infrastructure (marketing and sales) can monetize the drug's rights in a competitive environment.
%20of%20the%20company%20Petros%20Pharmaceuticals%20(PTPI)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Petros-Pharmaceuticals-PTPI&v=1772632281273 "Chart of market capitalization per employee (in thousands of dollars) of the company Petros Pharmaceuticals (PTPI)")
Market capitalization per employee (in thousands of dollars) in the market segment - Pharma other
Petros Pharmaceuticals focuses on the development and commercialization of men's health products. The company operates in a specific niche of the pharmaceutical market. This chart helps assess how the market views its product portfolio and commercial strategy, based on the marketing and sales team.
%20by%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Pharma-other&v=1772632281274 "Market capitalization per employee (in thousands of dollars) by market segment - Pharma other")
Market capitalization per employee (in thousands of dollars) for the overall market
Petros Pharmaceuticals focuses on men's health, offering medications for erectile dysfunction. The chart shows its valuation in the pharmaceutical sector. It reflects how its market value, based on its brand and sales, correlates with the team working on marketing and distribution of its products.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772632281274 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Petros Pharmaceuticals (PTPI)
Petros Pharmaceuticals specializes in men's health. Their key product is Stendra, a prescription medication for erectile dysfunction. They are a commercial pharmaceutical company. This chart shows how successfully their small sales and marketing department can compete with market giants (Viagra, Cialis) and generate profits.
%20Chart%20Petros%20Pharmaceuticals%20(PTPI)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Petros-Pharmaceuticals-PTPI&v=1772632281275 "Company Profit Per Employee (in thousands of dollars) Chart Petros Pharmaceuticals (PTPI)")
Profit per employee (in thousands of dollars) in the market segment - Pharma other
Petros Pharmaceuticals is a company specializing in men's health, best known for its erectile dysfunction drug Stendra. This metric reflects how successfully the company can sell its product in the face of fierce competition from established brands.
%20in%20the%20market%20segment%20-%20Pharma%20other&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Pharma-other&v=1772632281283 "Chart of profit per employee (in thousands of dollars) in the market segment - Pharma other")
Profit per employee (in thousands of dollars) for the market as a whole
Petros Pharmaceuticals (PTPI) is a biopharmaceutical company specializing in men's health (erectile dysfunction). It is a commercial business. This chart shows how successfully their marketing and sales generate profit per employee in a competitive yet profitable niche.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772632281286 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Petros Pharmaceuticals (PTPI)
Petros Pharmaceuticals focuses on men's health, specifically erectile dysfunction treatment. This chart demonstrates the commercial success of its products. The growth in revenue per employee demonstrates the effectiveness of its sales strategy, including the availability of over-the-counter medications, and its ability to compete in a large and established market.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Petros-Pharmaceuticals-PTPI&v=1772632281287 "Sales chart per company employee Petros Pharmaceuticals (PTPI)")
Sales per employee in the market segment - Pharma other
Petros Pharmaceuticals (PTPI) specializes in men's health. Their key product is Stendra, an erectile dysfunction drug they are working to make available over-the-counter (OTC). This chart shows how much revenue each employee generates from Stendra sales, reflecting their commercial performance.
Sales per employee for the market as a whole
Petros Pharmaceuticals (PTPI) specializes in men's health, with its best-known product being Stendra (a Viagra competitor). The company is focused on commercialization. This chart shows how effectively the company's small sales team generates revenue from sales of its niche drug in a highly competitive environment.
Short shares by company, segment and market as a whole
Shares shorted by company Petros Pharmaceuticals (PTPI)
Petros Pharmaceuticals specializes in men's health, specifically selling the erectile dysfunction drug Stendra. The bearish sentiment shown in this chart reflects investors' bets that Stendra will be unable to compete with the market-dominant giants Viagra and Cialis (and their cheaper generic versions).
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Petros-Pharmaceuticals-PTPI&v=1772632281289 "Short Shares Chart for the Company Petros Pharmaceuticals (PTPI)")
Shares shorted by market segment - Pharma other
This chart shows the overall investor skepticism toward the pharmaceutical sector. Petros Pharmaceuticals, which specializes in men's health, is in an industry where expectations are often skewed by regulatory risks and trial failures. This metric helps us understand whether investors believe in industry-wide breakthroughs or are betting on stagnation.
Shares shorted by the overall market
Petros Pharma sells men's health products. This chart illustrates the overall market pessimism. Investors fear that during a recession, consumers will skimp on lifestyle medications, which are often not covered by insurance. These discretionary expenses are among the first to be cut.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Petros Pharmaceuticals (PTPI)
Petros Pharmaceuticals specializes in men's health, primarily selling Stendra (a Viagra competitor). The company's success depends on marketing and sales growth in this competitive niche. This indicator shows when investors are "overheating" (above 70) the stock on growth expectations or "overselling" (below 30) on weak earnings.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Petros-Pharmaceuticals-PTPI&v=1772632281302 "RSI 14 indicator chart for the company's stock Petros Pharmaceuticals (PTPI)")
RSI 14 Market Segment - Pharma other
Petros Pharmaceuticals is a company specializing in men's health. Their key product is Stendra, a prescription erectile dysfunction drug, which they market. This chart reflects the overall sentiment in the biotech sector, helping to gauge the overall market sentiment toward this speculative industry.
RSI 14 for the overall market
Petros Pharma (PTPI) is a biotech R&D company. Like everyone in its sector, it's critically dependent on this schedule. Market euphoria offers the potential to easily raise hundreds of millions of dollars for research. Market panic poses the risk of running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast PTPI (Petros Pharmaceuticals)
Petros Pharma (PTPI) specializes in men's health products, primarily Stendra, a treatment for erectile dysfunction. This chart shows the average 12-month forecast. It reflects analysts' expectations for Stendra sales growth and the company's potential to obtain over-the-counter (OTC) approval.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-PTPI-Petros-Pharmaceuticals&v=1772632281321 "A chart showing analyst consensus forecasts for the expected stock price. PTPI (Petros Pharmaceuticals)")
The difference between the consensus estimate and the actual stock price PTPI (Petros Pharmaceuticals)
Petros (PTPI) is a "men's health" company. The company commercializes erectile dysfunction medications (Stendra). This chart shows the difference between the market valuation and the consensus forecast. It indicates whether experts believe they can compete with the giants (Viagra, Cialis) in this market.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-PTPI-Petros-Pharmaceuticals&v=1772632281327 "A chart showing the difference between the consensus forecast and the actual stock price. PTPI (Petros Pharmaceuticals)")
Analyst consensus forecast for stock prices by market segment - Pharma other
Petros Pharma is a "men's pharmacy." The company specializes in "men's health," selling erectile dysfunction medications (Stendra). This chart displays analysts' overall expectations for the *entire* pharmaceutical sector. It shows whether experts believe the market for lifestyle medications for men will grow.
Analysts' consensus forecast for the overall market share price
Petros Pharmaceuticals (PTPI) – men's health. They specialize in erectile dysfunction medications, some of which are available over-the-counter. This chart shows the general sentiment among experts. It reflects the extent to which analysts believe consumers will have extra money left over for lifestyle medications.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Petros Pharmaceuticals
Petros is a direct-to-consumer (D2C) pharmacy for men. They don't do R&D; their specialty is the acquisition (M&A) and direct-to-consumer (D2C, online) of older (over-the-counter) men's health medications (primarily Stendra for ED). This chart is a summary indicator of their D2C model. It reflects their (meager) sales and their (unprofitable) struggle to attract customers.
AKIMA Market Segment Index - Pharma other
Petros Pharmaceuticals (PTPI) is a pharma company focused on men's health. Their key product is Stendra, a Viagra competitor (an ED drug). This chart compares their composite index to the sector, showing how their niche male R&D strategy outperforms the competition.
The AKIM Index for the overall market
Petros Pharmaceuticals is a pharmaceutical company focused on men's health and the transition from prescription to over-the-counter (Rx-to-OTC) medications. This chart, which reflects the market average, provides a macro backdrop. It helps assess how PTPI, a niche player, stacks up against overall economic trends.
